Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic nimodipine for hearing preservation after vestibular schwannoma surgery
2019-002317-19Phase 3Active
- Sponsor
- Martin Luther University Halle-Wittenberg
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nimodipine in acoustic neuroma (2 arms), sponsored by Martin Luther University Halle-Wittenberg. Started Jan 2020; status: active.
02
Drugs
nimodipine
03
Conditions
acoustic neuroma
Beyond the preview
Go deeper on 2019-002317-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002317-19.